James P. Lee

Principal

Boston
+1-617-425-3116

The consulting experience of James P. Lee, MD, includes commercial and drug development engagements in the life sciences industry. Dr. Lee has developed product and portfolio strategies for clients across multiple therapeutic areas and executed due diligence supporting client transactions for biopharmaceutical assets through scientific and commercial/market analyses.

01

Understanding the PMA potential of future innovations in oncology

A leading pharmaceutical company sought support from CRA Life Sciences experts in the clinical development of several new monotherapy and combination products
View engagement
02

Pricing and market access potential for doublet and triplet regimens in endometrial cancer

CRA’s pricing and market access experts partnered with a global value and access team to develop the pricing and access strategy for novel combination...
View engagement

Life Sciences
CRA Insights

Antibody-drug conjugates: where are we now, where is it heading, and how can you get ahead of the opportunities and challenges with key stakeholders?

Antibody-drug conjugates (ADCs) hold great promise for the targeted treatment of cancer, and the market is expected to grow significantly in the upcoming...

James P. Lee

Boston +1-617-425-3116 jlee@crai.com

James P. Lee

Selected engagements

Latest insights

Antibody-drug conjugates: where are we now, where is it heading, and how can you get ahead of the opportunities and challenges with key stakeholders?

Recent events

US Oncology in 2024 and Beyond: A Payer Perspective Webinar

Oncology Practice Management Webinar

Credentials